CMIIU
Columbus Circle Capital Corp II UnitKey Statistics
About Columbus Circle Capital Corp II Unit
Columbus Circle Capital Corp II Unit (CMIIU) is a targeted acquisition vehicle focused on the life sciences sector, with particular emphasis on biotechnology, pharmaceuticals, and healthcare companies that exhibit substantial growth potential through strategic mergers and acquisitions. Backed by an experienced management team with deep industry knowledge, CMIIU aims to capitalize on emerging trends in healthcare and advancements in therapeutics and diagnostics. The company's strategic approach is designed to forge partnerships with innovative enterprises, underscoring its commitment to fostering sustainable innovation and maximizing long-term shareholder value.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | — |
| Operating Margin | 0.00% |
| Return on Equity | 0.00% |
| Return on Assets | 0.00% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $0.14 |
| Price-to-Book | — |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | 0 |
| Float | $27.47M |
| % Insiders | 0.00% |
| % Institutions | 64.12% |
Historical Volatility
Volatility is currently contracting
Turn research into an automated options-selling system
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on CMIIU and any ticker you trade — then tracks every position and per-strategy win rate.